Phytohormone abscisic acid ameliorates neuropathic pain via regulating LANCL2 protein abundance and glial activation at the spinal cord
Authors:
Open Access
- 25 June 2022
- journal article
- research article
- Published by SAGE Publications in Molecular Pain
- Vol. 18
Abstract
Spinal neuroinflammation plays a critical role in the genesis of neuropathic pain. Accumulating data suggest that abscisic acid (ABA), a phytohormone, regulates inflammatory processes in mammals. In this study, we found that reduction of the LANCL2 receptor protein but not the agonist ABA in the spinal cord is associated with the genesis of neuropathic pain. Systemic or intrathecal administration of ABA ameliorates the development and pre-existence of mechanical allodynia and heat hyperalgesia in animals with partial sciatic nerve ligation (pSNL). LANCL2 is expressed only in microglia in the spinal dorsal horn. Pre-emptive treatment with ABA attenuates activation of microglia and astrocytes, ERK activity, and TNFα protein abundance in the dorsal horn in rats with pSNL. These are accompanied by restoration of spinal LANCL2 protein abundance. Spinal knockdown of LANCL2 gene with siRNA recapitulates the behavioral and spinal molecular changes induced by pSNL. Activation of spinal toll-like receptor 4 (TLR4) with lipopolysaccharide leads to activation of microglia, and over production of TNFα, which are concurrently accompanied by suppression of protein levels of LANCL2 and peroxisome proliferator activated-receptor γ. These changes are ameliorated when ABA is added with LPS. The anti-inflammatory effects induced by ABA do not requires Gi protein activity. Our study reveals that the ABA/LANCL2 system is a powerful endogenous system regulating spinal neuroinflammation and nociceptive processing, suggesting the potential utility of ABA as the management of neuropathic pain.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (NS107569)
This publication has 75 references indexed in Scilit:
- Interactions between the immune and nervous systems in painNature Medicine, 2010
- Minocycline prevents impaired glial glutamate uptake in the spinal sensory synapses of neuropathic ratsNeuroscience, 2010
- Neuropathic Pain: A Maladaptive Response of the Nervous System to DamageAnnual Review of Neuroscience, 2009
- Abscisic Acid Released by Human Monocytes Activates Monocytes and Vascular Smooth Muscle Cell Responses Involved in AtherogenesisJournal of Biological Chemistry, 2009
- Abscisic Acid Activates the Murine Microglial Cell Line N9 through the Second Messenger Cyclic ADP-riboseJournal of Biological Chemistry, 2009
- Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complexNature Medicine, 2008
- The effects of thalidomide and minocycline on taxol-induced hyperalgesia in ratsBrain Research, 2008
- Glial–Cytokine–Neuronal Interactions Underlying the Mechanisms of Persistent PainThe Journal of Neuroscience, 2007
- Abscisic acid is an endogenous cytokine in human granulocytes with cyclic ADP-ribose as second messengerProceedings of the National Academy of Sciences, 2007
- Tumor necrosis factor alpha stimulates NMDA receptor activity in mouse cortical neurons resulting in ERK‐dependent deathJournal of Neurochemistry, 2006